NCT00858286View on ClinicalTrials.gov

A Follow-up Survey to Compare Stable Dosing (SERETIDE) With SYMBICORT, SMART, Maintenance and Reliever Therapy in One Inhaler in Moderate and Severe Asthmatics.

PHASE4CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

February 28, 2009

Primary Completion Date

April 30, 2010

Study Completion Date

April 30, 2010

Conditions
Asthma
Interventions
OTHER

Spirometry, PEF measurements and diary cards to evaluate control of Asthma

No intervention is made with the existing therapy, but patient will perform spirometry and PEF evaluations together with a registration of control of asthma in diary cards and health economic parameters in questionnaires

Trial Locations (1)

SE-171 77

GSK Investigational Site, Stockholm

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY